Further research is necessary to comprehend the influence of PERK and ATF6 signaling on disease progression and to investigate strategies for regulating the interplay of the three UPR mediators, aiming to prevent GVHD while maintaining GVL activity in allo-HCT. The gene discussed is EIF2AK3; the disease is graft versus host disease.